HNHPF(HNHPF)
HNHPF
No analyst ratings available
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $10.71T | $14.09T | $17.94T |
| Low | $10.34T | $11.20T | $15.59T |
| High | $11.10T | $16.51T | $19.96T |
| EBITDA Avg | $521.24B | $685.72B | $873.11B |
| Low | $503.05B | $544.98B | $759.01B |
| High | $540.36B | $803.58B | $971.52B |
| EBIT Avg | $391.86B | $515.52B | $656.39B |
| Low | $378.19B | $409.71B | $570.61B |
| High | $406.24B | $604.12B | $730.37B |
| Net Income Avg | $259.92B | $332.96B | $389.75B |
| Low | $215.76B | $276.39B | $323.54B |
| High | $298.00B | $381.74B | $446.86B |
| EPS Avg | $36.79 | $47.13 | $55.16 |
| Low | $30.54 | $39.12 | $45.79 |
| High | $42.18 | $54.03 | $63.25 |
| Analysts (Rev / EPS) | 17 / 1 | 20 / 1 | 9 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $2.81T | $3.33T | $3.09T | $3.50T | $3.64T | $4.16T |
| Low | $2.68T | $2.98T | $2.84T | $3.22T | $3.35T | $3.83T |
| High | $2.99T | $5.00T | $4.03T | $4.57T | $4.75T | $5.43T |
| EBITDA Avg | $136.87B | $162.25B | $150.17B | $170.43B | $177.04B | $202.50B |
| Low | $130.51B | $144.99B | $138.20B | $156.85B | $162.93B | $186.36B |
| High | $145.40B | $243.49B | $196.07B | $222.52B | $231.14B | $264.39B |
| EBIT Avg | $102.90B | $121.97B | $112.90B | $128.13B | $133.09B | $152.24B |
| Low | $98.11B | $109.00B | $103.90B | $117.92B | $122.49B | $140.10B |
| High | $109.31B | $183.05B | $147.40B | $167.28B | $173.77B | $198.76B |
| Net Income Avg | $79.98B | $92.30B | $81.97B | $90.59B | $97.90B | $109.28B |
| Low | $71.69B | $82.74B | $73.48B | $81.21B | $87.76B | $97.95B |
| High | $111.75B | $128.97B | $114.54B | $126.58B | $136.80B | $152.69B |
| EPS Avg | $9.77 | $11.28 | $10.02 | $11.07 | $11.96 | $13.35 |
| Low | $8.76 | $10.11 | $8.98 | $9.92 | $10.72 | $11.97 |
| High | $13.66 | $15.76 | $14.00 | $15.47 | $16.72 | $18.66 |
| Analysts (Rev / EPS) | 13 / 1 | 14 / 1 | 9 / 1 | 7 / 1 | 7 / 1 | 13 / 1 |